Nellix® Registry Study: EVAS-Global

UnknownOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2019

Study Completion Date

June 30, 2022

Conditions
Safety and Performance of the Nellix Endovascular Sealing System
Trial Locations (19)

1023

Auckland City Hospital Interventional Radiology, Auckland

2326

Hospital Hamar, Hamar

40225

Universitätsklinikum Düsseldorf Klinik für Gefäß- und Endovaskularchirurgie, Düsseldorf

45131

Alfried Krupp Krankenhaus Ruttenscheid, Vascular Centre, Essen

69120

Universitätsklinikum Heidelberg Klinik für Gefäßchirurgie Im Neuenheimer Feld, Heidelberg

70174

Klinikum Stuttgart Katharinenen Hospital, Stuttgart

86156

Klinikum Augsburg Klinik für Gefäßchirurgie, Augsburg

90471

Klinikum Sud Nuernberg, Dept of Vascular Surgery, Nuremberg

LV-1002

Pauls Stadins Clinical University Hospital Riga, Riga

L-2540

Hopital Kirchberg, Dept of Cardio-Vascular, Luxembourg-Kirchberg

1105AZ

Academisch Medisch Centrum Amsterdam, Department of Surgery, Amsterdam

6800 TA

Rijnstate Ziekenhuis, Vasculaire Centrum, Arnhem

3435 CM

St Antonius Ziekenhuis, Dept of Vascular Surgery, Nieuwegein

3015 CE

Erasmus Medical Centre, Dept of Vascular Surgery, Rotterdam

5022 GC

St Elisabeth Ziekenhuis, Dept of Vascular Surgery, Tilburg

Unknown

Orebro University Hospital, Department of General Surgery, Örebro

SE-171

Karolinska University Hospital, Stockholm

CB20QQ

Addenbrooke's Hospital, Dept of Vascular Surgery, Cambridge

SW170QT

St. George's Vascular Institute, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Endologix

INDUSTRY